The evolution and application of toxicity criteria

Area of Science:

• Oncology
• Clinical Trials
• Medical Informatics

Background:

• Toxicity assessment and reporting are fundamental in oncology.
• Standardized toxicity criteria systems facilitate comparisons across institutions and trials.
• The Common Toxicity Criteria (CTC) system has evolved, notably including acute radiation criteria.

Purpose of the Study:

• To highlight the need for a unified system for grading late effects in cancer treatment.
• To address the limitations posed by multiple, non-standardized late effects grading systems.
• To advocate for a common standard for late effects reporting, similar to acute effects.

Main Methods:

• Review of existing toxicity grading systems in oncology.
• Analysis of the impact of non-standardized systems on clinical trial comparability and research.
• Discussion of the ongoing development of a unified late effects grading system.

Main Results:

• Current use of multiple late effects grading systems hinders clinical trial comparability.
• Lack of standardization impedes the development of effective toxicity interventions.
• Progress in standardizing acute effects reporting contrasts with the need for late effects standardization.

Conclusions:

• A unified system for grading late effects in oncology is essential.
• Standardization will improve recognition, reporting, and management of late treatment toxicities.
• Active development of a unified late effects system is underway to address current limitations.